![Lloyd Mackenzie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lloyd Mackenzie
Präsident bei
Symvivo Corp.
Profil
Lloyd Mackenzie is currently the Director at Adapsyn Bioscience, Inc. and the President & Chief Operating Officer at Symvivo Corp.
He previously worked as a Research Scientist-Pharmaceutical Development at QLT, Inc. and as a Research Scientist at EACOM Timber Corp.
From 2017 to 2018, he was the Chief Operating Officer at Aquinox Pharmaceuticals, Inc. He also served as the Chief Development Officer at Notable Labs, Inc. and as the Chief Operating Officer at NervGen Pharma Corp.
from 2019 to 2020.
Additionally, he was the Chief Operating Officer at Neoleukin Therapeutics, Inc. Mr. Mackenzie received his undergraduate degree from Simon Fraser University.
Aktive Positionen von Lloyd Mackenzie
| Unternehmen | Position | Beginn |
|---|---|---|
Adapsyn Bioscience, Inc.
 Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focussed on the discovery and development of novel medicines | Direktor/Vorstandsmitglied | - |
Symvivo Corp.
 Symvivo Corp. BiotechnologyHealth Technology Operates clinical-stage gene therapy company that develops oral DNA vaccines for life threatening diseases | Präsident | 01.04.2018 |
Ehemalige bekannte Positionen von Lloyd Mackenzie
| Unternehmen | Position | Ende |
|---|---|---|
| NERVGEN PHARMA CORP. | Geschäftsführer | 02.10.2020 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Geschäftsführer | 01.12.2018 |
| NEUROGENE INC. | Geschäftsführer | 01.12.2018 |
Notable Labs, Inc.
 Notable Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops predictive medicines for patients with cancer | Corporate Officer/Principal | - |
EACOM Timber Corp.
 EACOM Timber Corp. Forest ProductsNon-Energy Minerals Engages in manufacturing, marketing and distribution of lumber and wood-based value-added products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lloyd Mackenzie
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals Engages in manufacturing, marketing and distribution of lumber and wood-based value-added products | Non-Energy Minerals |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Notable Labs, Inc.
Notable Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops predictive medicines for patients with cancer | Health Technology |
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focussed on the discovery and development of novel medicines | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Symvivo Corp.
Symvivo Corp. BiotechnologyHealth Technology Operates clinical-stage gene therapy company that develops oral DNA vaccines for life threatening diseases | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
